Showing 1,285 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Injectable & long-acting HIV treatment

HIV implant targets disease for up to a year

Editor's pick
The Engineer
26 September 2019
Changing treatment

FDA Expands Indications for Pifeltro and Delstrigo for HIV

Editor's pick
Medscape (requires free registration)
23 September 2019
New & experimental HIV treatments

ViiV Healthcare reports positive phase III study results of investigational, long-acting, injectable HIV-treatment regimen administered every two months

Editor's pick
GSK press release
22 August 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits regulatory application to EMA for the first monthly, injectable treatment for HIV

Editor's pick
ViiV press release
30 July 2019
People with limited treatment options

EMA panel recommends ibalizumab for multidrug-resistant HIV-1

Editor's pick
Medscape (requires free registration)
30 July 2019
Changing treatment

Biktarvy Suppresses HIV Well in Women and Those With Drug Resistance

Editor's pick
POZ
29 July 2019
People with limited treatment options

Fostemsavir salvage therapy continues to look good at 96 weeks

News
29 July 2019
Treatment simplification strategies

Dolutegravir dual therapy works well for both first line and maintenance treatment

News
29 July 2019
The search for a cure

First trial results of new immune-modulating drugs presented in Mexico City

News
26 July 2019
New & experimental HIV treatments

Islatravir plus doravirine may offer new dual therapy option

News
25 July 2019
Injectable & long-acting PrEP

PrEP implant could last well over a year

News
24 July 2019
New & experimental HIV treatments

2019 Pipeline Report

Editor's pick
TAG
23 July 2019
Injectable & long-acting HIV treatment

People with HIV express high satisfaction with monthly injectable regimen

News
23 July 2019
Pharmaceutical industry

GSK touts new Dovato switching data. Is it enough to shake Gilead's HIV lead?

Editor's pick
FiercePharma
11 July 2019
New & experimental HIV treatments

ViiV Healthcare receives EU marketing authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection

Editor's pick
ViiV press release
3 July 2019
New & experimental HIV treatments

1 Year After Approval: How Does D/C/F/TAF Measure Up?

Editor's pick
Contagion Live
1 July 2019
Vaginal rings & topical PrEP

Novel HIV-1 Inhibitor Shows Promise for Future Treatment of HIV in Women

Editor's pick
Infectious Disease Advisor
26 June 2019
Side effects

Major HIV drug calls for vigilance

Editor's pick
University of Duisberg-Essen
24 June 2019
HIV treatment for children & young people

Biktarvy Approved to Treat Pediatric Patients With HIV-1

Editor's pick
Monthly Prescribing Reference
20 June 2019
New & experimental HIV treatments

CytoDyn Announces Major Discovery for its Monotherapy Indication

Editor's pick
CytoDyn press release
20 June 2019
New & experimental HIV treatments

CytoDyn: Uncovering An Opportunity

Editor's pick
Seeking Alpha
12 June 2019
The search for a cure

Could gold be the key to making gene therapy for HIV, blood disorders more accessible?

Editor's pick
Phys.org
28 May 2019
New & experimental HIV treatments

CytoDyn Files Pivotal Trial Protocol for HIV Monotherapy with FDA

Editor's pick
CytoDyn press release
17 May 2019
Injectable & long-acting HIV treatment

NIH Trial Evaluates Long-acting HIV Medication Unable to Adhere to Strict Daily Regimens

Editor's pick
National Institute of Allergy and Infectious Diseases
9 May 2019